HOLLIS-EDEN PHARMACEUTICALS

Hollis-Eden Pharmaceuticals is focused on research and development of adrenal steroid hormones as pharmaceuticals for human health. Hollis-Eden Pharmaceuticals offers a hormonal signaling technology platform that develops small molecule compounds. The company offers TRIOLEX, a treatment for type 2 diabetes; and APOPTONE, a treatment for cancer. Hollis-Eden Pharmaceuticals was founded by Richard B. Hollis.